#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13038	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2097	617.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1673	1673	T	739	T,C	673,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13038	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2097	617.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1407	1407	C	767	C	728	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24110	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3672	655.1	0	.	n	.	0	T695C	SNP	695	695	T	1092	1092	C	710	C,T	675,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24110	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3672	655.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1734	1734	A	781	A,G	747,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24110	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3672	655.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2368	2368	C	758	C,T	713,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24110	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3672	655.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2442	2442	A	728	A	683	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24110	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3672	655.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2994	2994	C	739	C	687	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1844	folP	855	855	100.0	folP.l15.c4.ctg.1	1587	115.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1096	1098	AGC	191;193;192	A;G;C,A	176;178;177,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5090	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3362	151.0	1	SNP	p	S91F	1	.	.	271	273	TTC	568	570	TTC	175;175;174	T;T;C	167;167;164	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5090	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3362	151.0	1	SNP	p	D95G	1	.	.	283	285	GGC	580	582	GGC	167;168;167	G;G,A;C	159;161,1;160	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5090	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3362	151.0	1	SNP	p	G95N	0	.	.	283	285	GGC	580	582	GGC	167;168;167	G;G,A;C	159;161,1;160	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1508	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1327	113.4	1	SNP	p	G45D	0	.	.	133	135	GGC	497	499	GGC	187;192;193	G;G;C	176;175;179	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	786	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	982	79.5	0	.	n	.	0	A197.	DEL	197	197	A	546	546	A	203	A	189	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4814	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2869	167.2	1	SNP	p	D86N	0	.	.	256	258	GAC	542	544	GAC	201;201;203	G;A,G;C	186;177,1;190	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4814	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2869	167.2	1	SNP	p	R87I	0	.	.	259	261	CGT	545	547	CGT	203;200;198	C;G;T	189;186;177	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4814	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2869	167.2	1	SNP	p	R87W	0	.	.	259	261	CGT	545	547	CGT	203;200;198	C;G;T	189;186;177	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4814	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2869	167.2	1	SNP	p	S87R	1	.	.	259	261	CGT	545	547	CGT	203;200;198	C;G;T	189;186;177	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4814	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2869	167.2	1	SNP	p	S88P	0	.	.	262	264	TCC	548	550	TCC	197;198;199	T;C;C,A	180;184;183,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3984	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2733	145.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1579	1581	GGC	205;202;202	G;G;C	194;191;188	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3738	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2345	158.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1234	1236	GCA	205;202;206	G;C;A	186;183;192	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3738	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2345	158.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1237	1239	ATC	207;207;206	A;T;C	192;192;190	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3738	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2345	158.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1249	1251	GTG	212;211;212	G;T;G	193;192;195	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3738	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2345	158.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1249	1251	GTG	212;211;212	G;T;G	193;192;195	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3738	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2345	158.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1753	1755	ACC	209;210;211	A;C;C	189;190;189	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3738	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2345	158.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1807	1809	GCG	190;189;183	G;C;G	166;147;154	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3738	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2345	158.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1807	1809	GCG	190;189;183	G;C;G	166;147;154	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3738	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2345	158.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1930	1932	AGC	168;166;166	A;G;C	156;153;157	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3738	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2345	158.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1939	1941	GGC	162;161;162	G,A;G;C	152,1;151;149	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3738	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2345	158.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1957	1959	CCG	142;143;144	C,G;C;G	103,3;104;108	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5128	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3026	168.9	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1383	1385	ACG	203;201;195	A;C;G	188;186;182	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5128	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3026	168.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1521	1523	CCG	165;169;173	C,T;C;G	146,1;155;154	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2032	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1723	117.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	532	532	C	140	C,G	122,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2698	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1754	153.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	500	502	GAA	205;208;204	G,T;A;A	187,1;193;186	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2698	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1754	153.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	788	790	GAT	222;220;223	G;A;T	203;200;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2698	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1754	153.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	911	913	TCA	230;230;232	T;C;A	202;205;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2698	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1754	153.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1040	1042	GTC	232;231;228	G;T;C	215;213;211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2698	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1754	153.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1052	1054	TCT	227;224;221	T;C;T	211;208;208	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2698	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1754	153.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1370	1372	GCA	213;216;218	G;C,A;A	199;198,1;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2698	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1754	153.4	1	SNP	p	G120K	1	.	.	358	360	AAG	746	748	AAG	224;223;221	A;A;G	211;209;208	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2698	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1754	153.4	1	SNP	p	A121D	1	.	.	361	363	GAC	749	751	GAC	220;219;220	G;A;C	207;205;207	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2698	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1754	153.4	1	SNP	p	D121N	0	.	.	361	363	GAC	749	751	GAC	220;219;220	G;A;C	207;205;207	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9908	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4880	202.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1062	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1107	95.6	1	SNP	p	V57M	1	.	.	169	171	ATG	592	594	ATG	216;217;217	A;T;G	201;200;199	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
